|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.50 USD | +2.48% |
|
-15.10% | -29.78% |
| 16/07 | RxSight Names Aziz Mottiwala as CEO | MT |
| 14/07 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| Market Cap | 2.47B 2.16B 2B 1.83B 3.48B 238B 3.53B 23.82B 9.35B 116B 9.29B 9.09B 401B | P/E 2026 * |
-25.6x | P/E 2027 * | 34.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.47B 2.16B 2B 1.83B 3.48B 238B 3.53B 23.82B 9.35B 116B 9.29B 9.09B 401B | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 2.75x |
| Free-Float |
96.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | +2.48% | ||
| 1 week | -15.10% | ||
| Current month | -8.64% | ||
| 1 month | -7.03% | ||
| 3 months | -19.92% | ||
| 6 months | -21.93% | ||
| Current year | -29.78% |
| 1 week | 53.89 |  | 63.84 |
| 1 month | 53.89 | | 72.5 |
| Current year | 53.89 | | 83.92 |
| 1 year | 38.51 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 02/12/2022 |
| Director/Board Member | 71 | 01/12/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06 | Free | Director | 6,254 | 0.0145% | ||
| 25/06 | Free | Director | 7,463 | 0.0173% | ||
| 25/06 | Free | Director | 6,254 | 0.0145% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.48% | -15.10% | +41.70% | +225.78% | 2.47B | |
| +1.27% | +0.24% | +21.26% | -7.53% | 67.6B | |
| +1.38% | -5.23% | +38.08% | +197.15% | 51.32B | |
| +1.10% | +38.30% | +38.30% | +38.30% | 42.97B | |
| +0.81% | -2.21% | -50.39% | -52.57% | 40.81B | |
| +2.76% | -1.56% | +54.70% | -29.29% | 29.12B | |
| +1.25% | -7.48% | +116.21% | -43.73% | 27.09B | |
| +0.18% | -1.85% | +68.63% | +86.35% | 22.99B | |
| -2.37% | +9.55% | +9.74% | +200.32% | 21.55B | |
| -1.70% | +5.53% | +76.00% | +353.68% | 16.2B | |
| Average | +0.70% | -1.14% | +41.42% | +96.85% | 32.21B | |
| Weighted average by Cap. | +0.87% | -0.42% | +33.67% | +61.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 713M 623M 575M 528M 1B 68.57B 1.02B 6.86B 2.69B 33.52B 2.68B 2.62B 116B | 900M 787M 726M 667M 1.26B 86.63B 1.29B 8.67B 3.4B 42.34B 3.38B 3.31B 146B |
| Net income | -97.91M -85.61M -78.97M -72.59M -138M -9.42B -140M -943M -370M -4.6B -368M -360M -15.87B | 82.72M 72.32M 66.72M 61.33M 116M 7.96B 118M 796M 313M 3.89B 311M 304M 13.41B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | USD 57.50 | +2.48% | 1,467,064 |
| 14/07/26 | USD 56.11 | -5.40% | 2,079,500 |
| 13/07/26 | USD 59.31 | +2.01% | 1,113,250 |
| 10/07/26 | USD 58.14 | -9.35% | 2,367,158 |
| 09/07/26 | USD 64.14 | -5.30% | 2,168,792 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
